KLP Kapitalforvaltning AS Buys New Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)

KLP Kapitalforvaltning AS purchased a new position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 16,100 shares of the company’s stock, valued at approximately $634,000. A number of other large investors have also bought and sold shares of the stock. Charles Schwab Investment […]